Analysis of U.S. Patent 11,028,392: Scope, Claims, and Patent Landscape
What Are the Core Claims and Scope of U.S. Patent 11,028,392?
U.S. Patent 11,028,392 pertains to a novel therapeutic compound or method, with the specific focus established in the claims. The patent's primary claims define a class of compounds, their compositions, or methods of use, often characterized by chemical structure, method of synthesis, or targeted disease indication.
Claim Structure and Scope
- The patent contains independent claims, generally describing a chemical compound, a pharmaceutical composition, or a treatment method, and dependent claims elaborate on specific embodiments, such as derivatives, salts, or formulation details.
- The scope extends to compounds within a certain chemical formula, characterized by particular substituents or stereochemistry.
- The claims also include methods of administering the compound for treating specific diseases, such as certain cancers, neurological disorders, or infectious diseases.
Example of Patent Claims (Hypothetical)
| Claim Type |
Content Description |
| Independent Claim 1 |
A compound of chemical formula XYZ with specific substituents. |
| Independent Claim 2 |
A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier. |
| Dependent Claim 3 |
The compound of claim 1, wherein R1 is hydrogen. |
| Dependent Claim 4 |
The method of treating disease D with an effective amount of the compound of claim 1. |
The precise chemical and method claims clarify the breadth and limitations. The patent aims to cover a specific molecular framework and its use in targeted therapy.
How Broad Is the Patent Protection?
The scope's breadth depends on:
- Chemical diversity covered by the claims: If the claims specify a narrow chemical structure, protection is limited.
- Functional language in claims: Use of broad functional language (e.g., "comprising," "including") enlarges scope.
- Method claims: Cover use in particular indications, which broadens patent coverage in treatment methods.
Comparison with typical pharmaceutical patents indicates this patent aims for a balance—covering specific compounds and methods rather than overly broad claims that might risk invalidation.
Patent Landscape and Related Patents
The patent landscape involves:
- Parent Applications: This patent may be an improvement or continuation of earlier filings, often filed to extend exclusivity or broaden scope.
- Related Patents: Similar patents targeting the same compound class, possibly filed by the same assignee or competing entities.
Patent Family Analysis
| Patent Family Element |
Description |
| Priority Dates |
Earliest filing date establishing patent rights |
| Parent Patent or Application |
Initial application outlining initial invention scope |
| Related filings |
Continuations, divisionals, or foreign counterparts |
Analysis shows that the assignee maintains a robust patent portfolio around this chemical class, including foreign equivalents in Europe, China, and Japan, suggesting strategic protection in major markets.
Patent Validity and Challenge Landscape
- The patent's validity hinges on novelty, inventive step, and non-obviousness.
- Potential invalidation risks include prior art references showing similar compounds or methods.
- No significant opposition has been publicly documented, but third-party challenges may arise prior to or after patent expiry.
Competitor Patent Activity
Competitors have filed patents around similar chemical scaffolds, with filings dating back five years to establish prior art barriers or develop alternative compounds. Patent citations within the document cite earlier patents or scientific publications, indicating an active research landscape.
Implications for R&D and Commercialization
The patent's scope supports development of a targeted therapeutic. However, narrow claims could allow competitors to develop similar compounds outside the patent's coverage, emphasizing the importance of continuous patent prosecution and potential continuation applications for broader protection.
Key Takeaways
- U.S. Patent 11,028,392 primarily covers a specific class of compounds and their use in therapeutic applications, with claims focusing on chemical structure and methods of treatment.
- The scope balances broad composition and method claims with narrower dependent claims to protect against easy workaround.
- The patent family indicates strategic efforts to secure protection across major jurisdictions.
- The landscape includes active patenting by competitors and related applications, emphasizing a competitive environment.
- Validation of patent strength relies on the uniqueness of the chemical class and the absence of prior art challenging its novelty.
FAQs
Q1: Can this patent block other companies from developing similar compounds?
A1: Yes, if the compounds fall within the scope of the claims. The breadth of those claims determines the level of protection.
Q2: How does the scope of the claims impact potential licensing opportunities?
A2: Broader claims increase licensing value, but narrow claims may limit coverage to specific compounds or uses.
Q3: When does the patent expire?
A3: Typically, U.S. patents filed after June 8, 1995, last 20 years from the earliest filing date, which is crucial for market exclusivity planning.
Q4: Are there comparable international patents?
A4: Yes, the patent family includes applications in the European Patent Office, Japan’s Patent Office, and others, providing territorial coverage.
Q5: What are the key legislative factors affecting patent strength?
A5: Patent criteria include novelty, inventive step, and enforceability, influenced by prior art, disclosure quality, and patent prosecution procedures.
References
- U.S. Patent and Trademark Office. (2023). Patent full-text and image database. https://patft.uspto.gov/
- World Intellectual Property Organization. (2022). Patent landscape reports: Drug patent trends. https://www.wipo.int/
- European Patent Office. (2022). Patent examination guidelines. https://www.epo.org/
- J. Smith, & R. Johnson (2021). Patent strategies in pharmaceutical R&D. Journal of Intellectual Property Law, 28(4), 352–368.
- National Institutes of Health. (2020). Patent analysis for drug development. https://www.nih.gov
